What Happened? Shares of biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) jumped 2.5% in the afternoon session after the ...

On Wednesday, the U.S. Food and Drug Administration announced its approval of Rasonque, a new treatment option for people ...

In a randomized, open-label, multicenter trial of 500 adults with previously treated metastatic pancreatic adenocarcinoma, ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received FDA approval for expanded use of its PATHWAY® HER2 ...

BOSTON — Key DNA and chromosomal and immune cell changes in early-stage lung adenocarcinoma show significant associations with outcomes, representing potentially important early predictors to guide ...

Peter Mac researchers have identified potential new drug targets for pancreatic cancer by uncovering proteins cancer cells ...

The assays are now approved to assess HER2 status in gastric, gastroesophageal junction, and esophageal adenocarcinoma.

From 2000 to 2021, there was an increase in the incidence of pancreatic adenocarcinoma, which was seen in all age groups, according to a study published online April 14 in JAMA Network Open. Arvind ...

Zanidatamab-containing regimens prolonged progression-free survival (PFS) and overall survival in the first-line setting in patients with HER2-positive locally advanced or metastatic gastroesophageal ...